Page last updated: 2024-11-09

2,5-dimercapto-1,3,4-thiadiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimercaptothiadiazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2723630
CHEMBL ID3185279
SCHEMBL ID12495049
SCHEMBL ID19435
MeSH IDM0059235

Synonyms (74)

Synonym
bismuththiol
1,3,4-thiadiazol-dithiol-(2,5)
unii-2s78t9t08c
2s78t9t08c ,
BB 0260229
1072-71-5
2,5-dimercapto-thiadiazole
nsc-4645
dimercaptothiadiazole
1,4-thiadiazolidine-2,5-dithione
wln: t5nn dsj csh esh
usaf a-8354
nsc4645
bismuthiol i
2,5-dimercaptothiadiazole
2,3,4-thiodiazole
1,4-thiadiazole-2,5-dithiol
usaf fa-4
usafa-8354
1,3,4-thiadiazolidine-2,5-dithione
wln: t5nndsj csh esh
STK367101
1,3,4-thiadiazole-2,5-dithiol, 98%
ai3-18635
nsc 4645
2,5-dimercapto-1,3,4-thiodiazole
einecs 214-014-1
py 61h
1,3,4-thiadiazol-dithiol-(2,5) [german]
2,5-dimercapto-1,3,4-thiadiazole ,
1,3,4-thiadiazole-2,5-dithiol
bismuthiol
D0622
B0593
AKOS000119872
A24678
1,3,4-thiadiazolidine-2,5-dithione;2,5-dimercapto-1,3,4-thiodiazole
AKOS005485976
NCGC00248309-01
cas-1072-71-5
tox21_301157
dtxcid4020115
NCGC00255055-01
dtxsid6040115 ,
132120-63-9
5-sulfanyl-1,3,4-thiadiazole-2(3h)-thione
STK560428
79509-46-9
FT-0610390
PS-4046
AM20080025
1,3,4- thiadiazole-2,5-dithiol
SCHEMBL12495049
SCHEMBL19435
.delta.2-1,3,4-thiadiazoline-5-thione, 2-mercapto-
2,5-dithiol-1,3,4-thiadiazole
vanchem dmtd
132120-64-0
bismuththiol i
d 2 (chinese flotation agent)
d 2
Q-200066
STR02271
CHEMBL3185279
mfcd00003103
AKOS028108714
F1995-0275
bismuthiol i, for spectrophotometric det. of bi, cu, pb, sb, >=99.0%
1,3,4-thiadiazole-2-thione-5-thiol
[1,3,4]thiadiazole-2,5-dithiol
Q15632681
D88151
1,3,4-thiadiazole-2(3h)-thione, 5-mercapto-
EN300-17339
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency11.24960.007215.758889.3584AID1224835
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency17.72140.001022.650876.6163AID1224838; AID1224893
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency54.94100.023723.228263.5986AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency44.70700.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.21690.001628.015177.1139AID1259385
Histone H2A.xCricetulus griseus (Chinese hamster)Potency50.47720.039147.5451146.8240AID1224845
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency7.99700.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's1 (5.88)18.2507
2000's6 (35.29)29.6817
2010's7 (41.18)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.48 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index35.22 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.88%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]